Genentech Used IP To Form $1B Monopoly, HGS Says
Human Genome Sciences on Friday accused Genentech Inc. in federal court in Delaware of conspiring with Celltech R&D Ltd. to fraudulently obtain an antibody patent in order to create a monopoly...To view the full article, register now.
Already a subscriber? Click here to view full article